BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7500273)

  • 1. Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin.
    Oldenburg KR; Vo KT; Smith GA; Selick HE
    J Pharm Sci; 1995 Aug; 84(8):915-21. PubMed ID: 7500273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iontophoretic delivery of a telomeric oligonucleotide.
    Brand RM; Iversen PL
    Pharm Res; 1996 Jun; 13(6):851-4. PubMed ID: 8792421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of size and sequence on the iontophoretic delivery of oligonucleotides.
    Brand RM; Wahl A; Iversen PL
    J Pharm Sci; 1998 Jan; 87(1):49-52. PubMed ID: 9452967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iontophoresis of bases, nucleosides, and nucleotides.
    van der Geest R; Hueber F; Szoka FC; Guy RH
    Pharm Res; 1996 Apr; 13(4):553-8. PubMed ID: 8710745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iontophoretic transdermal delivery of buspirone hydrochloride in hairless mouse skin.
    Al-Khalili M; Meidan VM; Michniak BB
    AAPS PharmSci; 2003; 5(2):E14. PubMed ID: 12866941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iontophoretic transdermal delivery of haloperidol.
    Alvarez-Figueroa MJ; Araya-Silva I; Díaz-Tobar C
    Pharm Dev Technol; 2006; 11(3):371-5. PubMed ID: 16895847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intradermal delivery of antisense oligonucleotides by the pulse depolarization iontophoretic system.
    Aramaki Y; Arima H; Takahashi M; Miyazaki E; Sakamoto T; Tsuchiya S
    Biol Pharm Bull; 2003 Oct; 26(10):1461-6. PubMed ID: 14519955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the poor iontophoretic transport of lysozyme across the skin: when high charge and high electrophoretic mobility are not enough.
    Dubey S; Kalia YN
    J Control Release; 2014 Jun; 183():35-42. PubMed ID: 24657950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential use of iontophoresis for transdermal delivery of NF-kappaB decoy oligonucleotides.
    Hashim II; Motoyama K; Abd-Elgawad AE; El-Shabouri MH; Borg TM; Arima H
    Int J Pharm; 2010 Jun; 393(1-2):127-34. PubMed ID: 20417264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An experimental model for interpreting percutaneous penetration of oligonucleotides that incorporates the role of keratinocytes.
    Brand RM; Haase K; Hannah TL; Iversen PL
    J Invest Dermatol; 1998 Dec; 111(6):1166-71. PubMed ID: 9856834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal iontophoresis of hydromorphone across hairless rat skin in vitro.
    Kumar MG; Lin S
    Pharm Dev Technol; 2009; 14(1):106-15. PubMed ID: 18825546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of iontophoretic parameters for the transdermal delivery of methotrexate.
    Vemulapalli V; Banga AK; Friden PM
    Drug Deliv; 2008 Sep; 15(7):437-42. PubMed ID: 18712621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irontophoresis: transdermal delivery of iron by iontophoresis.
    Murthy SN; Vaka SR
    J Pharm Sci; 2009 Aug; 98(8):2670-6. PubMed ID: 19117049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parameters controlling topical delivery of oligonucleotides by electroporation.
    Regnier V; Le Doan T; Préat V
    J Drug Target; 1998; 5(4):275-89. PubMed ID: 9713977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal iontophoretic drug delivery: advances and challenges.
    Ita K
    J Drug Target; 2016; 24(5):386-91. PubMed ID: 26406291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.
    Cázares-Delgadillo J; Naik A; Ganem-Rondero A; Quintanar-Guerrero D; Kalia YN
    Pharm Res; 2007 Jul; 24(7):1360-8. PubMed ID: 17457661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iontophoretic drug delivery.
    Kalia YN; Naik A; Garrison J; Guy RH
    Adv Drug Deliv Rev; 2004 Mar; 56(5):619-58. PubMed ID: 15019750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal iontophoresis of insulin: III. Influence of electronic parameters.
    Pillai O; Kumar N; Dey CS; Borkute ; Sivaprasad N; Panchagnula R
    Methods Find Exp Clin Pharmacol; 2004; 26(6):399-408. PubMed ID: 15349135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.